摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-bromo-2,5-bis(3-methoxyphenyl)thiophene | 1193525-53-9

中文名称
——
中文别名
——
英文名称
3-bromo-2,5-bis(3-methoxyphenyl)thiophene
英文别名
——
3-bromo-2,5-bis(3-methoxyphenyl)thiophene化学式
CAS
1193525-53-9
化学式
C18H15BrO2S
mdl
——
分子量
375.286
InChiKey
MCOKNRACGHWKDW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    46.7
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-bromo-2,5-bis(3-methoxyphenyl)thiophene3-甲氧基苯硼酸四(三苯基膦)钯 、 sodium carbonate 作用下, 以 甲苯 为溶剂, 反应 20.0h, 以34%的产率得到2,3,5-tris(3-methoxyphenyl)thiophene
    参考文献:
    名称:
    New Insights into the SAR and Binding Modes of Bis(hydroxyphenyl)thiophenes and -benzenes: Influence of Additional Substituents on 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitory Activity and Selectivity
    摘要:
    17 beta-Hydroxystcroid dehydrogenase type 1 (17 beta-HSD1) is responsible for the catalytic reduction of weakly active E1 to highly potent E2. E2 stimulates the proliferation of hormone-dependent diseases via activation of the estrogen receptor alpha (ER alpha). Because of the overexpression of 17 beta-HSD1 in mammary tumors, this enzyme should be an attractive target for the treatment of estrogen-dependent pathologies. Recently, we have reported on a series of potent 17 beta-HSD1 inhibitors: bis(hydroxyphenyl) azoles, thiophenes, and benzenes. In this paper, different substituents are introduced into the core structure and the biological properties of the corresponding inhibitors are evaluated. Computational methods and analysis of different X-rays of 17 beta-HSD1 lead to identification of two different binding modes for these inhibitors. The fluorine compound 23 exhibits an IC50 of 8 nM and is the most potent nonsteroidal inhibitor described so far. It also shows a high selectivity (17 beta-HSD2, ER alpha) and excellent pharmacokinetic properties after peroral application to rats.
    DOI:
    10.1021/jm901195w
  • 作为产物:
    描述:
    3,5-dibromo-2-(3-methoxyphenyl)thiophene3-甲氧基苯硼酸四(三苯基膦)钯 、 sodium carbonate 作用下, 以 甲苯 为溶剂, 反应 20.0h, 以72%的产率得到3-bromo-2,5-bis(3-methoxyphenyl)thiophene
    参考文献:
    名称:
    New Insights into the SAR and Binding Modes of Bis(hydroxyphenyl)thiophenes and -benzenes: Influence of Additional Substituents on 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitory Activity and Selectivity
    摘要:
    17 beta-Hydroxystcroid dehydrogenase type 1 (17 beta-HSD1) is responsible for the catalytic reduction of weakly active E1 to highly potent E2. E2 stimulates the proliferation of hormone-dependent diseases via activation of the estrogen receptor alpha (ER alpha). Because of the overexpression of 17 beta-HSD1 in mammary tumors, this enzyme should be an attractive target for the treatment of estrogen-dependent pathologies. Recently, we have reported on a series of potent 17 beta-HSD1 inhibitors: bis(hydroxyphenyl) azoles, thiophenes, and benzenes. In this paper, different substituents are introduced into the core structure and the biological properties of the corresponding inhibitors are evaluated. Computational methods and analysis of different X-rays of 17 beta-HSD1 lead to identification of two different binding modes for these inhibitors. The fluorine compound 23 exhibits an IC50 of 8 nM and is the most potent nonsteroidal inhibitor described so far. It also shows a high selectivity (17 beta-HSD2, ER alpha) and excellent pharmacokinetic properties after peroral application to rats.
    DOI:
    10.1021/jm901195w
点击查看最新优质反应信息

文献信息

  • DIARYLETHENE COMPOUNDS AND USES THEREOF
    申请人:SWITCH MATERIALS, INC.
    公开号:US20160083398A1
    公开(公告)日:2016-03-24
    A compound according to Formula IA and IB, reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer A and a ring-closed isomer B is provided. For substitutent groups, Z is N, O or S; each R 1 is independently selected from the group consisting of H, or halo; each R 2 is independently selected from the group consisting of H, halo, a polymer backbone, alkyl or aryl; or, when both R 2 together form —CH═CH— and form part of a polymer backbone; each R 3 is independently selected from the group consisting of H, halo, alkyl, alkoxy, thioalkyl or aryl; each R 4 is aryl; and each R 5 is independently selected from the group consisting of H, halo, alkyl, alkoxy, thioalkyl or aryl.
    本发明提供了一种按照式IA和IB的化合物,在光致变色和电致变色条件下,可在环开放异构体A和环闭合异构体B之间可逆地转化。对于取代基,Z为N、O或S;每个R1独立地选自H或卤素;每个R2独立地选自H、卤素、聚合物骨架、烷基或芳基;或者,当两个R2一起形成-CH═CH-并形成聚合物骨架的一部分时;每个R3独立地选自H、卤素、烷基、烷氧基、硫代烷基或芳基;每个R4为芳基;每个R5独立地选自H、卤素、烷基、烷氧基、硫代烷基或芳基。
  • Diarylethene compounds and uses thereof
    申请人:SWITCH MATERIALS, INC.
    公开号:US10072023B2
    公开(公告)日:2018-09-11
    A compound according to Formula IA and IB, reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer A and a ring-closed isomer B is provided. For substitutent groups, Z is N, O or S; each R1 is independently selected from the group consisting of H, or halo; each R2 is independently selected from the group consisting of H, halo, a polymer backbone, alkyl or aryl; or, when both R2 together form —CH═CH— and form part of a polymer backbone; each R3 is independently selected from the group consisting of H, halo, alkyl, alkoxy, thioalkyl or aryl; each R4 is aryl; and each R5 is independently selected from the group consisting of H, halo, alkyl, alkoxy, thioalkyl or aryl.
    提供了一种根据式 IA 和 IB 的化合物,该化合物在光致变色和电致变色条件下可在开环异构体 A 和闭环异构体 B 之间进行可逆转换。对于取代基,Z 是 N、O 或 S;每个 R1 独立地选自 H 或卤代;每个 R2 独立地选自 H、卤代、聚合物骨架、烷基或芳基;或者,当两个 R2 一起形成 -CH═CH- 并构成聚合物骨架的一部分时;每个 R3 独立地选自由 H、卤素、烷基、烷氧基、硫代烷基或芳基组成的组;每个 R4 是芳基;每个 R5 独立地选自由 H、卤素、烷基、烷氧基、硫代烷基或芳基组成的组。
  • PHOTOCHROMIC AND ELECTROCHROMIC DIARYLCYCLOPENTENE DERIVATIVES AS OPTICAL FILTERS
    申请人:Switch Materials, Inc.
    公开号:EP2760969A1
    公开(公告)日:2014-08-06
  • US20140256936A1
    申请人:——
    公开号:US20140256936A1
    公开(公告)日:2014-09-11
  • US9227986B2
    申请人:——
    公开号:US9227986B2
    公开(公告)日:2016-01-05
查看更多